SCHEMBL24587730

SCHEMBL24587730

CC/C=C\CCCCOC(CCCC(=O)OCC)OCCCC/C=C\CC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
CYP3A4 P08684 1/20 0.61
ALOX15 P16050 1/20 0.61
TSHR P16473 1/20 0.61
HSD17B10 Q99714 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
NR1I2 O75469 1/20 0.60
PGR P06401 1/20 0.60
ADORA3 P0DMS8 1/20 0.60
PTGS2 P35354 1/20 0.60
PDE4D Q08499 1/20 0.60
CYP1A2 P05177 1/20 0.42
MGLL Q99685 1/20 0.42
CNR1 P21554 2/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
CNR2 P34972 1/20 0.41
LPAR2 Q9HBW0 2/20 0.40
LPAR3 Q9UBY5 2/20 0.40
LPAR1 Q92633 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24588790 0.88 ALDH1A1 (0.47) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL30592511 0.88 MGLL (0.51) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL29774930 0.87 ALDH1A1 (0.49) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL29774852 0.87 ALDH1A1 (0.49) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL24587888 0.87 ALDH1A1 (0.49) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL24588565 0.87 ALDH1A1 (0.49) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL30726554 0.84 ALDH1A1 (0.48) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL24588894 0.84 ALDH1A1 (0.49) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL24588714 0.84 F7 (0.55) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL24588789 0.83 ALDH1A1 (0.51) ALDH1A1CYP3A4ALOX15TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331657-A1 NANOMATERIALS COMPRISING ESTER-LINKED ACETALS BEAM THERAPEUTICS INC. 2023-10-19 US disclosed
US-20230331657-A1 NANOMATERIALS COMPRISING ESTER-LINKED ACETALS BEAM THERAPEUTICS INC. 2023-10-19 US disclosed
CN-116887841-A Nanomaterials comprising ester-linked acetals 比姆医疗股份有限公司 2023-10-13 CN disclosed
WO-2023121964-A1 NANOMATERIALS COMPRISING DISULFIDES BEAM THERAPEUTICS INC. (US) 2023-06-29 WO disclosed
WO-2022140252-A1 NANOMATERIALS COMPRISING ESTER-LINKED ACETALS BEAM THERAPEUTICS INC. (US) 2022-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331657-A1 NANOMATERIALS COMPRISING ESTER-LINKED ACETALS LIPA, SGMS1, SGMS2 ALDH1A1 331/4885CYP3A4 2342/4885ALOX15 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.